Ever Source Wealth Advisors, LLC Vanda Pharmaceuticals Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 110 shares of VNDA stock, worth $579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110Holding current value
$579% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VNDA
# of Institutions
151Shares Held
45.3MCall Options Held
20KPut Options Held
999K-
Black Rock Inc. New York, NY8.14MShares$42.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$18.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.45MShares$18.2 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$16.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$13.6 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $298M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...